HKDC1 promotes the tumorigenesis and glycolysis in lung adenocarcinoma via regulating AMPK/mTOR signaling pathway
出版年份 2020 全文链接
标题
HKDC1 promotes the tumorigenesis and glycolysis in lung adenocarcinoma via regulating AMPK/mTOR signaling pathway
作者
关键词
-
出版物
Cancer Cell International
Volume 20, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-09-12
DOI
10.1186/s12935-020-01539-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- HKDC1 C-terminal based peptides inhibit extranodal natural killer/T-cell lymphoma by modulation of mitochondrial function and EBV suppression
- (2020) Qi Chen et al. LEUKEMIA
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- High metabolic rate and stem cell characteristics of esophageal cancer stem‐like cells depend on the Hsp27‐AKT‐HK2 pathway
- (2019) Chen‐Chi Liu et al. INTERNATIONAL JOURNAL OF CANCER
- B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2
- (2019) Tongguo Shi et al. Cell Death & Disease
- PGC1β Regulates Breast Tumor Growth and Metastasis by SREBP1-Mediated HKDC1 Expression
- (2019) Xiaoli Chen et al. Frontiers in Oncology
- Emerging roles of aerobic glycolysis in breast cancer
- (2019) Z. Wu et al. Clinical & Translational Oncology
- CircRNA-ENO1 promoted glycolysis and tumor progression in lung adenocarcinoma through upregulating its host gene ENO1
- (2019) Jiayu Zhou et al. Cell Death & Disease
- Atg7 inhibits Warburg effect by suppressing PKM2 phosphorylation resulting reduced epithelial-mesenchymal transition
- (2018) Yanling Feng et al. International Journal of Biological Sciences
- Studies on the Tissue Localization of HKDC1, a Putative Novel Fifth Hexokinase, in Humans
- (2018) Md. Wasim Khan et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Targeted Therapy and Immunotherapy in the Treatment of Non–Small Cell Lung Cancer
- (2018) Girish S. Shroff et al. RADIOLOGIC CLINICS OF NORTH AMERICA
- The Circadian Clock Regulates Metabolic Phenotype Rewiring Via HKDC1 and Modulates Tumor Progression and Drug Response in Colorectal Cancer
- (2018) Luise Fuhr et al. EBioMedicine
- Hepatic hexokinase domain containing 1 (HKDC1) improves whole body glucose tolerance and insulin sensitivity in pregnant mice
- (2018) Md. Wasim Khan et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- High expression of hexokinase domain containing 1 is associated with poor prognosis and aggressive phenotype in hepatocarcinoma
- (2016) Zijian Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth
- (2016) Huanan Wang et al. Cancer Cell International
- HKDC1 Is a Novel Hexokinase Involved in Whole-Body Glucose Use
- (2016) Anton E. Ludvik et al. ENDOCRINOLOGY
- Resveratrol inhibits Hexokinases II mediated glycolysis in non-small cell lung cancer via targeting Akt signaling pathway
- (2016) Wei Li et al. EXPERIMENTAL CELL RESEARCH
- MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer
- (2015) Weijie Guo et al. HEPATOLOGY
- Coordinated regulatory variation associated with gestational hyperglycaemia regulates expression of the novel hexokinase HKDC1
- (2015) Cong Guo et al. Nature Communications
- Hexokinase 2-Mediated Warburg Effect Is Required for PTEN- and p53-Deficiency-Driven Prostate Cancer Growth
- (2014) Lei Wang et al. Cell Reports
- Inferring therapeutic targets from heterogeneous data: HKDC1 is a novel potential therapeutic target for cancer
- (2013) Gong-Hua Li et al. BIOINFORMATICS
- Tumor glycolysis as a target for cancer therapy: progress and prospects
- (2013) Shanmugasundaram Ganapathy-Kanniappan et al. Molecular Cancer
- LKB1/AMPK/mTOR signaling pathway in hematological malignancies: From metabolism to cancer cell biology
- (2011) Alexa S. Green et al. CELL CYCLE
- AMP-activated protein kinase--an energy sensor that regulates all aspects of cell function
- (2011) D. G. Hardie GENES & DEVELOPMENT
- Perspectives on inhibiting mTOR as a future treatment strategy for hematological malignancies
- (2010) N Chapuis et al. LEUKEMIA
- Targeting AMPK: A new therapeutic opportunity in breast cancer
- (2008) Sirwan M. Hadad et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now